Fact CheckerSign in

NCT05594862Active, not recruiting

Treatment of Crohn's Complex Perianal Fistulas With Tissue Transplantation by Local Injection of Micro-fragmented Autologous Adipose Tissue.

Treatment of Crohn's Complex Perianal Fistulas With Tissue Transplantation by Local Injection of Micro-fragmented Autologous Adipose Tissue. Multicenter Randomized Controlled Prospective Study

Source: ClinicalTrials.gov · Last updated 27 Mar 2026

Brief summary (registry, in English)

multicentre randomized controlled prospective study aimed at evaluating the efficacy of the infiltration of microfractured adipose tissue in the healing of perianal fistulas not-responding to treatment with biologics, in order to improve the quality of life and significantly reduce the risk of definitive ostomy.

Status (registry)
Active, not recruiting
Study type
Interventional
Enrollment
80 (estimated)
First submitted
13 Oct 2022
Start date
9 Jan 2023
Primary completion date
9 Apr 2025
Lead sponsor
Lipogems International spa
NCT number
NCT05594862

What you commit to

  • Study type: Interventional
  • Planned participants: 80
  • From 9 Jan 2023 to the primary completion date, 9 Apr 2025
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Patients with active HIV infections, hepatitis C (HCV), hepatitis B (HBV), tuberculosis.
  • Patients with abdominal localization of Crohn's disease who may require general surgery during the study.
  • Patients with active oncological or lymphoproliferative diseases from which it was not possible to safely withdraw an adequate quantity of lipoaspirate (at least 60 cc).
  • Patients with clinical conditions that may compromise the success of the surgery or the follow-up.

Other

  • Patients with more than 1 internal and 3 external openings.
  • Patients with ileus / colo ostomy.
  • Patients with anus / rectum-vaginal fistulas.
  • Pregnant or breastfeeding women.

Who the study is looking for

  • The patient's age is over 18 at the time of surgery.
  • The patient suffers from Crohn's disease confirmed by instrumental and histological methods.
  • The patient presents with complex perianal fistulising disease refractory to standard treatment (combination of surgical drainage of sepsis and local / systemic administration of anti-TNF-α for at least 1 year)
  • The patient received, understood and signed informed consent for active participation in the study.
  • The patient is able to understand the conditions of the study and to participate throughout the duration.

Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
IRCCS S Orsola Malpighi
Coordinator of this site? Confirm its status
BolognaItalyUnknown status

This page is information, not medical advice. Discuss any trial with your doctor.